By selecting the 'Yes, leave Amgen.co.th option you understand that you are leaving the corporate page of Amgen Thailand and that you will be redirected to another Internet site belonging to third parties, for whose content or opinions Amgen Thailand is not responsible for and makes no representations regarding such content or its accuracy. By selecting this option and accessing linked third party sites, you understand that you do so at your own risk.
The website to which you will be redirected may be designed exclusively for residents of a particular country or countries, as advertised on that website. As a consequence, the website to which you will be directed may contain information on pharmaceutical products or indications that are not approved in Thailand. If you reside in a country other than the one to which such website is directed, please contact your local Amgen affiliate for the correct information on products in your country of residence.
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.
Amgen Thailand was established in 2015 to make our innovative medicines available to patients in the community suffering from serious illnesses. We have been a committed partner to the local healthcare industry ever since, working closely with the government and industry organizations to encourage mutual growth and create a positive environment that meets patient needs.
The synergy of Thailand’s growing biomedicine market, innovative research programs, and strong government support makes it well positioned to shape the future of the biotechnology industry in the region. Amgen looks forward to being a key driver in the local biotechnology community and helping to advance the growth of this industry in Thailand.
Find out why Amgen operates at a different rhythm, accelerating the pace of change at the cutting edge of medical discovery, inventing powerful new therapies and reliably delivering them to patients.
The rhythm of life unfolds at an ever-changing pace. Some moments pass in a blur. Others tick by in slow motion.
But no matter what the pace of life, nothing is more valuable than the time we have to experience it— and the chance we have to live each moment to its fullest.
That’s why Amgen operates at a different rhythm, moving quickly toward the future by combatting the world’s toughest diseases.
With roots in the biotech revolution, today Amgen is one of the world’s leading independent biotech companies.
With each decade, we stay on the cutting edge of medical discovery, inventing powerful therapies— and reliably delivering them to patients.
We fight the toughest diseases, such as cancer, heart disease, asthma, and osteoporosis to help millions of people globally.
We live in a new era of human health. And Amgen continues to accelerate the pace of change-- operating sustainably and drawing upon our deep knowledge of science to push beyond what’s known today.
We tap into a vast library of human and genetic data to unearth new insights into treating disease. We are creating new therapies that are more precise and personalized than ever before, advancing medicines that can work in new ways, such as targeting multiple pathways in the body at the same time.
Machine learning and artificial intelligence help us make medicines more quickly and effectively by helping to predict if they’ll be safe and effective.
We’re also removing barriers that limit equitable access to healthcare to make our medicines available to more patients around the world.
At Amgen, our mission is to serve patients because we want these rhythms of life to continue. We want you, and your loved ones, to make every moment count—and to count on having more moments.
Our belief—and the core of our strategy—is that innovative, highly differentiated medicines that provide large clinical benefits in addressing serious diseases are medicines that will not only help patients, but also will help reduce the social and economic burden of disease in society today.
Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology innovator since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.
Home to a population of 70 million, the advent of an aging population coupled with the increasing burden of non-communicable disease (NCDs) creates a significant strain on the healthcare system, economy, and livelihoods in Thailand. We believe that our innovative, highly differentiated medicines will not only help patients, but also reduce the social and economic burden of disease in Thai communities today.